UK researchers have developed two synthetic molecules that coax stem cells to differentiate into either neurons or epithelial cells for use in drug discovery applications.
Serologicals has continued its acquisitive streak, buying the cell
culture business Specialty Media from Sentigen Holding Corp, for
$6.5m (€4.9m) in cash. The unit will be integrated into
Serologicals' Chemicon subsidiary.